Impact of Cyanocobalamin and Methylcobalamin on Inflammatory Bowel Disease and the Intestinal Microbiota Composition

被引:43
|
作者
Zhu, Xuan [1 ]
Xiang, Shasha [1 ]
Feng, Xiao [1 ]
Wang, Huanhuan [2 ]
Tian, Shiyi [1 ]
Xu, Yuanyuan [1 ]
Shi, Lihua [1 ]
Yang, Lu [2 ]
Li, Mian [3 ]
Shen, Yubiao [4 ]
Chen, Jie [1 ]
Chen, Yuewen [1 ]
Han, Jianzhong [1 ]
机构
[1] Zhejiang Gongshang Univ, Sch Food Sci & Bioengn, 18 Xuezheng St, Hangzhou 310018, Zhejiang, Peoples R China
[2] Hangzhou Normal Univ, Sch Med, Hangzhou 310018, Zhejiang, Peoples R China
[3] Zhejiang Huakang Pharmaceut Co Ltd, Quzhou 324302, Zhejiang, Peoples R China
[4] Tsinghua Univ, Yangtze Delta Reg Inst, Jiaxing 314000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cyanocobalamin; methylcobalamin; gut microbiome; inflammatory bowel disease; Enterobacteriaceae; VITAMIN-B-12; GUT; COLITIS; PATHOGENESIS; DEFICIENCY;
D O I
10.1021/acs.jafc.8b05730
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Patients with inflammatory bowel disease (IBD) are usually advised to supplement various types of vitamin B-12, because vitamin B-12 is generally absorbed in the colon. Thus, in the current study, the influence of cyanocobalamin (CNCBL) or methylcobalamin (MECBL) ingestion on IBD symptoms will be investigated. Then, whether and how the application of various cobalamins would modify the taxonomic and functional composition of the gut microbiome in mice will be examined carefully. Dextran-sulfate-sodium-induced IBD mice were treated with MECBL or CNCBL; disease activity index (DAI) scores and intestinal inflammatory conditions of mice were evaluated. Fecal samples were collected; microbiota composition was determined with a 16s rRNA analysis; functional profiles were predicted by phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt); and short-chain fatty acids were measured. The consequence of higher relative abundances of Enterobacteriaceae and isomeric short-chain fatty acids by cobalamin treatment revealed that a high concentration of CNCBL but not MECBL supplementation obviously aggravated IBD. A microbial ecosystem rich in Escherichia/Shigella and low in Lactobacillus, Blautia, and Clostridium XVIII was observed in IBD mice after a high concentration of CNCBL supplementation. In cobalamin-dependent enzymes, CNCBL was more efficient in the adenosylcobalamin system than MECBL and vice versa in the MECBL system. The distinct effects of various cobalamins were associated with the distribution and efficiency of vitamin-B-12-dependent riboswitches. CNCBL had a strong inhibitory effect on all riboswitches, especially on btuB and pocR riboswitches from Enterobacteriaceae. CNCBL aggravated IBD via enhancing the proportion of Enterobacteriaceae organisms through riboswitch and enzyme systems. The present study provides a critical reference for offering a suitable amount and type of cobalamin during a symbiotic condition.
引用
收藏
页码:916 / 926
页数:11
相关论文
共 50 条
  • [31] Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease
    Lopetuso, L. R.
    Petito, V.
    Zambrano, D.
    Orlando, D.
    Dal Lago, A.
    Serrichhio, L.
    Papa, A.
    Gasbarrini, A.
    Scaldaferri, F.
    DIGESTIVE DISEASES, 2016, 34 (03) : 202 - 209
  • [32] The crosstalk between oral and intestinal microbiota in inflammatory bowel disease patients
    Xiang, B.
    Runzhi, C.
    Min, Z.
    Yuanqi, Z.
    Xiang, P.
    Wei, W.
    Qi, Z.
    Zhiyin, G.
    Jun, H.
    Tao, D.
    Min, Z.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2145 - I2145
  • [33] Regulation of the intestinal microbiota:An emerging therapeutic strategy for inflammatory bowel disease
    Bei Yue
    Zhi-Lun Yu
    Cheng Lv
    Xiao-Long Geng
    Zheng-Tao Wang
    Wei Dou
    World Journal of Gastroenterology, 2020, (30) : 4378 - 4393
  • [34] Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease
    Zhang, Jie
    Gan, Huilin
    Duan, Xiaoyan
    Li, Guangming
    BIOMEDICINES, 2024, 12 (10)
  • [35] Intestinal Microbiota: From Inflammatory Bowel Disease to Bone Marrow Transplantation
    Holler, Ernst
    Oefner, Peter
    Landfried, Karin
    Koestler, Josef
    Huber, Elisabeth
    Peter, Katrin
    Ammer, Julia
    Rogler, Gerhard
    Kreutz, Marina
    Spang, Rainer
    Hehlgans, Thomas
    Edinger, Matthias
    Wolff, Daniel
    Gessner, Andre
    Andreesen, Reinhard
    BLOOD, 2012, 120 (21)
  • [36] Impact of Ethnicity, Geography, and Disease on the Microbiota in Health and Inflammatory Bowel Disease
    Prideaux, Lani
    Kang, Seungha
    Wagner, Josef
    Buckley, Michael
    Mahar, Jackie E.
    De Cruz, Peter
    Wen, Zhonghui
    Chen, Liping
    Xia, Bing
    van Langenberg, Daniel R.
    Lockett, Trevor
    Ng, Siew C.
    Sung, Joseph J. Y.
    Desmond, Paul
    McSweeney, Chris
    Morrison, Mark
    Kirkwood, Carl D.
    Kamm, Michael A.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (13) : 2906 - 2918
  • [37] The microbiota in inflammatory bowel disease
    Sheehan, Donal
    Moran, Carthage
    Shanahan, Fergus
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (05) : 495 - 507
  • [38] The microbiota in inflammatory bowel disease
    Donal Sheehan
    Carthage Moran
    Fergus Shanahan
    Journal of Gastroenterology, 2015, 50 : 495 - 507
  • [39] Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease
    Vrakas, Spyros
    Mountzouris, Konstantinos C.
    Michalopoulos, George
    Karamanolis, George
    Papatheodoridis, George
    Tzathas, Charalampos
    Gazouli, Maria
    PLOS ONE, 2017, 12 (01):
  • [40] Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
    Vila, Arnau Vich
    Imhann, Floris
    Collij, Valerie
    Jankipersadsing, Soesma A.
    Gurry, Thomas
    Mujagic, Zlatan
    Kurilshikov, Alexander
    Bonder, Marc Jan
    Jiang, Xiaofang
    Tigchelaar, Ettje F.
    Dekens, Jackie
    Peters, Vera
    Voskuil, Michiel D.
    Visschedijk, Marijn C.
    van Dullemen, Hendrik M.
    Keszthelyi, Daniel
    Swertz, Morris A.
    Franke, Lude
    Alberts, Rudi
    Festen, Eleonora A. M.
    Dijkstra, Gerard
    Masclee, Ad A. M.
    Hofker, Marten H.
    Xavier, Ramnik J.
    Alm, Eric J.
    Fu, Jingyuan
    Section, Cisca Wijmenga
    Section, Daisy M. A. E. Jonkers
    Zhernakova, Alexandra
    Weersma, Rinse K.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (472)